User profiles for François Coutlée
 | Francois CoutléeUniversité de Montréal Verified email at ssss.gouv.qc.ca Cited by 15056 |
[HTML][HTML] Human papillomavirus DNA versus Papanicolaou screening tests for cervical cancer
…, A Ferenczy, S Ratnam, F Coutlée… - … England Journal of …, 2007 - Mass Medical Soc
Background To determine whether testing for DNA of oncogenic human papillomaviruses (HPV)
is superior to the Papanicolaou (Pap) test for cervical-cancer screening, we conducted …
is superior to the Papanicolaou (Pap) test for cervical-cancer screening, we conducted …
The natural history of type-specific human papillomavirus infections in female university students
…, M Abrahamowicz, A Ferenczy, F Coutlée… - … Biomarkers & Prevention, 2003 - AACR
Little is known about the average duration of type-specific human papillomavirus (HPV)
infections and their patterns of persistence. The objectives of this study were to evaluate the rate …
infections and their patterns of persistence. The objectives of this study were to evaluate the rate …
Are self-collected samples comparable to physician-collected cervical specimens for human papillomavirus DNA testing? A systematic review and meta-analysis
OBJECTIVE.: To compare the detection rate of genital human papillomavirus (HPV)
infection in self- and physician-obtained samples. DESIGN.: Systematic review and meta-analysis. …
infection in self- and physician-obtained samples. DESIGN.: Systematic review and meta-analysis. …
Enhanced detection and typing of human papillomavirus (HPV) DNA in anogenital samples with PGMY primers and the Linear array HPV genotyping test
F Coutlée, D Rouleau, P Petignat… - Journal of clinical …, 2006 - Am Soc Microbiol
The Roche PGMY primer-based research prototype line blot assay (PGMY-LB) is a convenient
tool in epidemiological studies for the detection and typing of human papillomavirus (HPV…
tool in epidemiological studies for the detection and typing of human papillomavirus (HPV…
Human papillomavirus infection and oral cancer: a case-control study in Montreal, Canada
The objective of the present study was to examine the association between human
papillomavirus (HPV) infection and risk of developing oral cancer. The investigation followed a …
papillomavirus (HPV) infection and risk of developing oral cancer. The investigation followed a …
Human papillomavirus and HIV coinfection and the risk of neoplasias of the lower genital tract: a review of recent developments
ONE OF THE RISK FACTORS FOR HUMAN PAPILLOMAVIRUS (HPV) INFECTION and
subsequent lower genital tract neoplasias and cancers is impaired cell-mediated immunity. HIV-…
subsequent lower genital tract neoplasias and cancers is impaired cell-mediated immunity. HIV-…
Modeling the sexual transmissibility of human papillomavirus infection using stochastic computer simulation and empirical data from a cohort study of young women in …
The authors estimated plausible ranges of the probability of human papillomavirus (HPV)
transmission per coital act among newly forming couples by using stochastic computer …
transmission per coital act among newly forming couples by using stochastic computer …
Use of PGMY primers in L1 consensus PCR improves detection of human papillomavirus DNA in genital samples
The novel PGMY L1 consensus primer pair is more sensitive than the MY09 and MY11
primer mix for detection and typing with PCR of human papillomavirus (HPV) DNA in genital …
primer mix for detection and typing with PCR of human papillomavirus (HPV) DNA in genital …
HAART and progression to high-grade anal intraepithelial neoplasia in men who have sex with men and are infected with HIV
(See the editorial commentary by Severini, on pages 1182–1183 .) Background . Human
immunodeficiency virus (HIV)–seropositive men who have sex with men (MSM) are at risk for …
immunodeficiency virus (HIV)–seropositive men who have sex with men (MSM) are at risk for …
Population-level impact of the bivalent, quadrivalent, and nonavalent human papillomavirus vaccines: a model–based analysis
…, MH Mayrand, EV Kliewer, F Coutlée… - Journal of the …, 2012 - academic.oup.com
Background Bivalent and quadrivalent human papillomavirus (HPV) vaccines are now
licensed in several countries. Furthermore, clinical trials examining the efficacy of a nonavalent …
licensed in several countries. Furthermore, clinical trials examining the efficacy of a nonavalent …
